CSR Report

The report covers Hanmi Pharm's 2018 sustainability performance, prepared in accordance with the GRI Standards Core Option and independently assured. It highlights approximately KRW 1.16 trillion in revenue, 93.7% revenue from products developed in-house, and a 30-drug global pipeline. Environmental performance includes 787,172 GJ of total energy consumption and 49,244 tCO2e of Scope 1 and Scope 2 emissions, while waste recycling reached 46%. The report also describes companywide CSR and EHS oversight and a workforce of 2,399 employees.